首页> Hepatology (Baltimore, Md.)> Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma models.

Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma models.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mincheng,Yu

第一单位： Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.;Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

作者： Mincheng,Yu ^[1] ; Jack W,Sample ^[2] ; Irene K,Yan ^[3] ; Shohei,Takaichi ^[2] ; Jennifer L,Tomlinson ^[2] ; Emilien J,Loeuillard ^[4] ; Ryan D,Watkins ^[2] ; Nathan W,Werneburg ^[4] ; Amro M,Abdelrahman ^[2] ; Danielle,Carlson ^[4] ; Hendrien,Kuipers ^[2] ; Meina,Cai ^[5] ; Enis H,Ozmert ^[4] ; Brooke,Kimball ^[6] ; Jinchun,Yang ^[4] ; Sumera I,Ilyas ^[7] ; Gregory J,Gores ^[4] ; Tushar,Patel ^[3] ; Rory L,Smoot ^[8]

作者单位： Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.;Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. ^[1] Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA. ^[2] Division of Gastroenterology and Hepatology, Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA. ^[3] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. ^[4] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.;Division of Infectious Disease, Sun Yat-Sen University, Guangzhou, China. ^[5] Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA. ^[6] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.;Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA. ^[7] Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.;Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA. ^[8]

关键词 Hippo pathway bile duct tumors mitochondria tyrosine kinase inhibitor